These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36893522)

  • 1. Secondary cough headache: Independent course of headache and response to a COX-2 inhibitor.
    Farag M; Bahra A
    Clin Neurol Neurosurg; 2023 Apr; 227():107646. PubMed ID: 36893522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary stabbing headache can be responsive to etoricoxib, a selective COX-2 inhibitor.
    O'Connor MB; Murphy E; Phelan MJ; Regan MJ
    Eur J Neurol; 2008 Jan; 15(1):e1. PubMed ID: 18171381
    [No Abstract]   [Full Text] [Related]  

  • 3. Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders.
    Farag M; Bahra A
    Headache; 2022 Mar; 62(3):383-388. PubMed ID: 35277974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible cerebral vasoconstriction syndrome possibly induced by etoricoxib.
    Dallocchio C; Arbasino C; Borutti G; Gola G; Egitto MG
    Clin Neuropharmacol; 2014; 37(5):154-7. PubMed ID: 25229174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
    Laine L; Curtis SP; Cryer B; Kaur A; Cannon CP;
    Lancet; 2007 Feb; 369(9560):465-73. PubMed ID: 17292766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
    Cannon CP; Curtis SP; FitzGerald GA; Krum H; Kaur A; Bolognese JA; Reicin AS; Bombardier C; Weinblatt ME; van der Heijde D; Erdmann E; Laine L;
    Lancet; 2006 Nov; 368(9549):1771-81. PubMed ID: 17113426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with paracetamol, ketorolac or etoricoxib did not hinder alveolar bone healing: a histometric study in rats.
    Fracon RN; Teófilo JM; Moris IC; Lamano T
    J Appl Oral Sci; 2010 Dec; 18(6):630-4. PubMed ID: 21308296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal exfoliation as a selective reaction to etoricoxib.
    Patanè M; Isola S; Gangemi S; Minciullo PL
    J Clin Pharm Ther; 2016 Dec; 41(6):722-724. PubMed ID: 27576781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global gastrointestinal safety profile of etoricoxib and lumiracoxib.
    Yuan Y; Hunt RH
    Curr Pharm Des; 2007; 13(22):2237-47. PubMed ID: 17691997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study.
    Johnell K; Fastbom J
    Clin Drug Investig; 2008; 28(11):687-95. PubMed ID: 18840011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib.
    Hunt RH; Harper S; Callegari P; Yu C; Quan H; Evans J; James C; Bowen B; Rashid F
    Aliment Pharmacol Ther; 2003 Jan; 17(2):201-10. PubMed ID: 12534404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects.
    Schwartz JI; Dallob AL; Larson PJ; Laterza OF; Miller J; Royalty J; Snyder KM; Chappell DL; Hilliard DA; Flynn ME; Cavanaugh PF; Wagner JA
    J Clin Pharmacol; 2008 Jun; 48(6):745-54. PubMed ID: 18434566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
    Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
    Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Headache after coughing: consider cough headache].
    Nap LG; van den Berg JS; de Jong G
    Ned Tijdschr Geneeskd; 2009; 153():A465. PubMed ID: 19857288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.
    Bickham K; Kivitz AJ; Mehta A; Frontera N; Shah S; Stryszak P; Popmihajlov Z; Peloso PM
    BMC Musculoskelet Disord; 2016 Aug; 17():331. PubMed ID: 27502582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
    El Miedany Y; Youssef S; Ahmed I; El Gaafary M
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy.
    Dubois RW; Melmed GY; Henning JM; Laine L
    Aliment Pharmacol Ther; 2004 Jan; 19(2):197-208. PubMed ID: 14723611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term tolerability of etoricoxib in different types of NSAID-intolerant subjects.
    Pagani M; Bonadonna P; Dama A; Senna GE; Vescovi PP; Antico A
    Eur Ann Allergy Clin Immunol; 2010 Dec; 42(6):216-20. PubMed ID: 21287945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.
    Doña I; Blanca-López N; Jagemann LR; Torres MJ; Rondón C; Campo P; Gómez AI; Fernández J; Laguna JJ; Rosado A; Blanca M; Canto G
    Allergy; 2011 Nov; 66(11):1428-33. PubMed ID: 21834936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.